•
Mar 31, 2024

Repligen Q1 2024 Earnings Report

Repligen's first quarter results were reported, showing a revenue of $151 million.

Key Takeaways

Repligen reported a solid first quarter with a revenue of $151 million. The company saw growth in the Filtration franchise excluding COVID and continued strength from new modality customers. The company is maintaining its adjusted 2024 financial guidance, expecting orders to pick up during the second half of the year.

First quarter revenue was reported as $151 million.

New modalities revenue increased by 16% year-over-year.

Filtration (non-COVID) revenue increased by 12% year-over-year.

A nine-month book-to-bill ratio of 1.03 was achieved.

Total Revenue
$151M
Previous year: $183M
-17.1%
EPS
$0.28
Previous year: $0.64
-56.3%
Gross Margin
49.5%
Previous year: 55.2%
-10.3%
Gross Profit
$75M
Previous year: $101M
-25.6%
Cash and Equivalents
$781M
Previous year: $618M
+26.3%
Free Cash Flow
$36.4M
Previous year: $2.65M
+1274.7%
Total Assets
$2.85B
Previous year: $2.54B
+12.3%

Repligen

Repligen

Repligen Revenue by Segment

Forward Guidance

Repligen reiterated its financial guidance for the full year 2024. The company expects total reported revenue between $620M - $650M.

Positive Outlook

  • Revenue is expected to be between $620M and $650M.
  • Gross margin is expected to be between 49% and 50%.
  • Income from operations is projected to be between $38.5M and $43.5M.
  • Operating margin is expected to be between 6% and 7%.
  • Net income is forecasted to be between $28.5M and $32.5M.

Challenges Ahead

  • Year-over-year change in total reported revenue is expected to be between -3% and 2%.
  • Base revenue growth is expected to be between -1% and 4%.
  • Other income (expense) is expected to be between ($1M) and $0.
  • Tax rate on pre-tax income is expected to be 23%.
  • Earnings per share - diluted is expected to be between $0.51 and $0.58.

Revenue & Expenses

Visualization of income flow from segment revenue to net income